Sunshine Biopharma, Inc. (SBFM)
USD 2.75
(0.37%)
USD 2.75
(0.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 24.09 Million | 4.34 Million | 228.42 Thousand | 71.41 Thousand | 21.12 Thousand | 447.2 Thousand |
| Cost of Revenue | 15.75 Million | 2.64 Million | 117.83 Thousand | 25.84 Thousand | 11.05 Thousand | 391.08 Thousand |
| Gross Profit | 8.33 Million | 1.69 Million | 110.59 Thousand | 45.56 Thousand | 10.07 Thousand | 56.11 Thousand |
| Operating Expenses | 13.12 Million | 10.37 Million | 2.55 Million | 622.43 Thousand | 651.7 Thousand | 1.22 Million |
| Selling, General and Administrative Expenses | 10.82 Million | 9.47 Million | 1.86 Million | 547.42 Thousand | 622.72 Thousand | 1.2 Million |
| Research and Development Expenses | 1.85 Million | 811.85 Thousand | 672.2 Thousand | 60.94 Thousand | 15.2 Thousand | 12.8 Thousand |
| Other Expenses | 438.88 Thousand | 80.39 Thousand | 12.74 Thousand | 14.06 Thousand | 13.77 Thousand | -871.72 Thousand |
| Cost and Expenses | 28.87 Million | 13.01 Million | 2.66 Million | 648.28 Thousand | 662.75 Thousand | 1.61 Million |
| Operating Income | -4.78 Million | -8.67 Million | -2.44 Million | -576.87 Thousand | -641.63 Thousand | -1.16 Million |
| Interest Expense | 137.3 Thousand | 39.41 Thousand | 328.81 Thousand | 168.1 Thousand | 115.9 Thousand | 159.42 Thousand |
| Income Tax Expense | 395.16 Thousand | 233.3 Thousand | 328.81 Thousand | -1.88 Million | 383.38 Thousand | -41.52 Thousand |
| Earnings before Tax | -4.11 Million | -26.51 Million | -12.43 Million | -2.78 Million | -1.07 Million | -2.15 Million |
| Net Income | -4.5 Million | -26.74 Million | -12.76 Million | -897.68 Thousand | -1.46 Million | -2.15 Million |
| Earnings Per Share Basic | -370.41 | -3523.64 | -9774.32 | -1036.59 | -828.01 | -141.54 |
| Earnings Per Share Diluted | -370.41 | -3523.64 | -9774.32 | -1036.59 | -828.01 | -141.54 |
| Weighted Average Shares Outstanding | 12.16 Thousand | 7590.00 | 1306.00 | 866.00 | 1765.00 | 15.23 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 12.16 Thousand | 7590.00 | 1306.00 | 866.00 | 1765.00 | 15.23 Thousand |
| Gross Margin | 0.35 | 0.39 | 0.48 | 0.64 | 0.48 | 0.13 |
| EBIT Margin | -0.16 | -1.87 | -10.63 | -36.65 | -44.63 | -4.45 |
| Profit Margin | -0.19 | -6.15 | -55.88 | -12.57 | -69.19 | -4.82 |
| EBITDA | -3.82 Million | -26.44 Million | -12.09 Million | -2.6 Million | -948.38 Thousand | -1.94 Million |
| Earnings Before Tax Margin | -0.20 | -2.00 | -10.68 | -8.08 | -30.38 | -2.61 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 9.3 Million | 7.54 Million | 7.68 Million | 24.09 Million | 5.95 Million | 5.56 Million |
| Cost of Revenue | 6.99 Million | 5.22 Million | 5.15 Million | 15.9 Million | 3.96 Million | 3.6 Million |
| Gross Profit | 2.3 Million | 2.31 Million | 2.52 Million | 8.19 Million | 1.99 Million | 1.95 Million |
| Operating Expenses | 3.57 Million | 3.66 Million | 3.42 Million | 12.97 Million | 2.76 Million | 2.94 Million |
| Selling, General and Administrative Expenses | 3.13 Million | 3.44 Million | 2.6 Million | - | 2.44 Million | 2.44 Million |
| Research and Development Expenses | 436.23 Thousand | 222.03 Thousand | 816.32 Thousand | - | 238.01 Thousand | 368.56 Thousand |
| Other Expenses | 196.67 Thousand | - | -98.42 Thousand | -289.74 Thousand | - | - |
| Cost and Expenses | 10.57 Million | 8.89 Million | 8.57 Million | 28.87 Million | 6.73 Million | 6.55 Million |
| Operating Income | -1.26 Million | -1.35 Million | -897.48 Thousand | -4.78 Million | -779.47 Thousand | -989.62 Thousand |
| Interest Expense | 245.00 | 49.18 Thousand | 30.11 Thousand | 137.3 Thousand | 38.52 Thousand | 27.59 Thousand |
| Income Tax Expense | -343.69 Thousand | 22.35 Thousand | 220.26 Thousand | 395.16 Thousand | 40.95 Thousand | 87.67 Thousand |
| Earnings before Tax | -837.99 Thousand | -1.26 Million | -1.02 Million | -4.11 Million | -610.53 Thousand | -814.43 Thousand |
| Net Income | -494.3 Thousand | -1.28 Million | -1.25 Million | -4.5 Million | -651.48 Thousand | -902.1 Thousand |
| Earnings Per Share Basic | -9.94 | -40.04 | -104.69 | - | -50.72 | -0.71 |
| Earnings Per Share Diluted | -9.94 | -40.04 | -104.69 | - | -50.72 | -0.71 |
| Weighted Average Shares Outstanding | 49.72 Thousand | 32.06 Thousand | 11.94 Thousand | 12.16 Thousand | 12.84 Thousand | 1.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 49.72 Thousand | 32.06 Thousand | 11.94 Thousand | 12.16 Thousand | 12.84 Thousand | 1.26 Million |
| Gross Margin | 0.25 | 0.31 | 0.33 | 0.34 | 0.33 | 0.35 |
| EBIT Margin | -0.13 | -0.17 | -0.11 | - | -0.09 | -0.14 |
| Profit Margin | -0.05 | -0.17 | -0.16 | -0.19 | -0.11 | -0.16 |
| EBITDA | -1.21 Million | -1.3 Million | -855.13 Thousand | - | -534.83 Thousand | -751.69 Thousand |
| Earnings Before Tax Margin | -0.14 | -0.18 | -0.12 | -0.20 | -0.13 | -0.18 |
7164
BJTRF
5236
GRYRF
BWB
BAJAJHCARE